News Sentiment

ENSC sentiment intelligence

Ensysce Biosciences Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.28 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+4.8% over one week, +4.2% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Ensysce Biosciences (ENSC) price target decreased by 34.79% to 16.78

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 4.8% Price confirming higher
Trend fit Trend inactive 4.2% over four weeks
Fair value -96.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 33
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 10
Market source 7
TradingView 6
TradingKey 6
Investing.com 3
ChartMill 2
MT Newswires 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 14
Analyst action 1
Balance sheet 1
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
TradingKey Direct company coverage

Ensysce Biosciences Inc (ENSC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Ensysce Biosciences Inc (ENSC), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators. It notes ENSC's stock is trading between resistance at $0.32 and support at $0.

Tone
Negative 40/100
Event
Market update
Published
18 Jun 2026 10:09
Source
TradingKey
ChartMill Direct company coverage

ENSC Stock Chart | ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC)

This page from ChartMill.com provides a stock chart and current price information for ENSYSCE BIOSCIENCES INC (NASDAQ:ENSC). It shows the stock's performance, including daily, weekly, and monthly views, along with technical and fundamental analysis options. The current stock pric

Tone
Neutral 50/100
Event
Market update
Published
06 Jun 2026 02:09
Source
ChartMill
Finviz Direct company coverage

ENSC - Ensysce Biosciences Inc Stock Price and Quote

This page provides a detailed overview of Ensysce Biosciences Inc (ENSC) stock, including its latest trading information, financial metrics, and a comprehensive list of recent news and press releases. It highlights the company's focus on developing tamper-proof opioids with overd

Tone
Neutral 50/100
Event
Market update
Published
05 Jun 2026 01:09
Source
Finviz
Stock Titan Direct company coverage

Ensysce Biosciences (NASDAQ: ENSC) registers up to 1.3M shares for resale

Ensysce Biosciences (NASDAQ: ENSC) has filed an S-3 registration statement to register up to 1.3 million shares of common stock for resale. These shares are primarily issuable to a manufacturing counterparty and through a separate agreement, with proceeds from resales going to th

Tone
Negative 36/100
Event
Market update
Published
04 Jun 2026 20:38
Source
Stock Titan
Investing.com Direct company coverage

Ensysce Biosciences receives Nasdaq notice for non-compliance with equity rule

Ensysce Biosciences (NASDAQ: ENSC) has received a notice from Nasdaq for non-compliance with the minimum stockholders' equity requirement, falling below the $2.5 million threshold as of March 31, 2026. The company must submit a plan to regain compliance within 45 days to avoid de

Tone
Negative 20/100
Event
Market update
Published
22 May 2026 23:39
Source
Investing.com
Stock Titan Direct company coverage

Ensysce Biosciences (NASDAQ: ENSC) warned on Nasdaq equity listing rule

Ensysce Biosciences Inc. (NASDAQ: ENSC) has received a notice from Nasdaq regarding its non-compliance with the minimum $2.5 million stockholders’ equity requirement as of March 31, 2026. The company has 45 days, until July 6, 2026, to submit a plan to regain compliance, with a p

Tone
Negative 19/100
Event
Market update
Published
22 May 2026 20:39
Source
Stock Titan